This report contains market size and forecasts of Vaccine Development Service in Global, including the following market information:
Global Vaccine Development Service Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Vaccine Development Service market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Therapeutic Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Vaccine Development Service include WuXi AppTec, Charles River Laboratories, Creative Biolabs, Creative Biostructure, PPD, Merck, Sartorius, Eurofins Scientific and Statens Serum Institut, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Publisher has surveyed the Vaccine Development Service companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Vaccine Development Service Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Vaccine Development Service Market Segment Percentages, by Type, 2021 (%)
Therapeutic
Prophylactic
Other
Global Vaccine Development Service Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Vaccine Development Service Market Segment Percentages, by Application, 2021 (%)
Enterprise
Government
Global Vaccine Development Service Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Vaccine Development Service Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Vaccine Development Service revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Vaccine Development Service revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
WuXi AppTec
Charles River Laboratories
Creative Biolabs
Creative Biostructure
PPD
Merck
Sartorius
Eurofins Scientific
Statens Serum Institut
Thermo Fisher Scientific
TRANSVAC
Azenta US
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Vaccine Development Service Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Vaccine Development Service Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Vaccine Development Service Overall Market Size
2.1 Global Vaccine Development Service Market Size: 2021 VS 2028
2.2 Global Vaccine Development Service Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Vaccine Development Service Players in Global Market
3.2 Top Global Vaccine Development Service Companies Ranked by Revenue
3.3 Global Vaccine Development Service Revenue by Companies
3.4 Top 3 and Top 5 Vaccine Development Service Companies in Global Market, by Revenue in 2021
3.5 Global Companies Vaccine Development Service Product Type
3.6 Tier 1, Tier 2 and Tier 3 Vaccine Development Service Players in Global Market
3.6.1 List of Global Tier 1 Vaccine Development Service Companies
3.6.2 List of Global Tier 2 and Tier 3 Vaccine Development Service Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Vaccine Development Service Market Size Markets, 2021 & 2028
4.1.2 Therapeutic
4.1.3 Prophylactic
4.1.4 Other
4.2 By Type - Global Vaccine Development Service Revenue & Forecasts
4.2.1 By Type - Global Vaccine Development Service Revenue, 2017-2022
4.2.2 By Type - Global Vaccine Development Service Revenue, 2023-2028
4.2.3 By Type - Global Vaccine Development Service Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Vaccine Development Service Market Size, 2021 & 2028
5.1.2 Enterprise
5.1.3 Government
5.2 By Application - Global Vaccine Development Service Revenue & Forecasts
5.2.1 By Application - Global Vaccine Development Service Revenue, 2017-2022
5.2.2 By Application - Global Vaccine Development Service Revenue, 2023-2028
5.2.3 By Application - Global Vaccine Development Service Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Vaccine Development Service Market Size, 2021 & 2028
6.2 By Region - Global Vaccine Development Service Revenue & Forecasts
6.2.1 By Region - Global Vaccine Development Service Revenue, 2017-2022
6.2.2 By Region - Global Vaccine Development Service Revenue, 2023-2028
6.2.3 By Region - Global Vaccine Development Service Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Vaccine Development Service Revenue, 2017-2028
6.3.2 US Vaccine Development Service Market Size, 2017-2028
6.3.3 Canada Vaccine Development Service Market Size, 2017-2028
6.3.4 Mexico Vaccine Development Service Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Vaccine Development Service Revenue, 2017-2028
6.4.2 Germany Vaccine Development Service Market Size, 2017-2028
6.4.3 France Vaccine Development Service Market Size, 2017-2028
6.4.4 U.K. Vaccine Development Service Market Size, 2017-2028
6.4.5 Italy Vaccine Development Service Market Size, 2017-2028
6.4.6 Russia Vaccine Development Service Market Size, 2017-2028
6.4.7 Nordic Countries Vaccine Development Service Market Size, 2017-2028
6.4.8 Benelux Vaccine Development Service Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Vaccine Development Service Revenue, 2017-2028
6.5.2 China Vaccine Development Service Market Size, 2017-2028
6.5.3 Japan Vaccine Development Service Market Size, 2017-2028
6.5.4 South Korea Vaccine Development Service Market Size, 2017-2028
6.5.5 Southeast Asia Vaccine Development Service Market Size, 2017-2028
6.5.6 India Vaccine Development Service Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Vaccine Development Service Revenue, 2017-2028
6.6.2 Brazil Vaccine Development Service Market Size, 2017-2028
6.6.3 Argentina Vaccine Development Service Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Vaccine Development Service Revenue, 2017-2028
6.7.2 Turkey Vaccine Development Service Market Size, 2017-2028
6.7.3 Israel Vaccine Development Service Market Size, 2017-2028
6.7.4 Saudi Arabia Vaccine Development Service Market Size, 2017-2028
6.7.5 UAE Vaccine Development Service Market Size, 2017-2028
7 Players Profiles
7.1 WuXi AppTec
7.1.1 WuXi AppTec Corporate Summary
7.1.2 WuXi AppTec Business Overview
7.1.3 WuXi AppTec Vaccine Development Service Major Product Offerings
7.1.4 WuXi AppTec Vaccine Development Service Revenue in Global Market (2017-2022)
7.1.5 WuXi AppTec Key News
7.2 Charles River Laboratories
7.2.1 Charles River Laboratories Corporate Summary
7.2.2 Charles River Laboratories Business Overview
7.2.3 Charles River Laboratories Vaccine Development Service Major Product Offerings
7.2.4 Charles River Laboratories Vaccine Development Service Revenue in Global Market (2017-2022)
7.2.5 Charles River Laboratories Key News
7.3 Creative Biolabs
7.3.1 Creative Biolabs Corporate Summary
7.3.2 Creative Biolabs Business Overview
7.3.3 Creative Biolabs Vaccine Development Service Major Product Offerings
7.3.4 Creative Biolabs Vaccine Development Service Revenue in Global Market (2017-2022)
7.3.5 Creative Biolabs Key News
7.4 Creative Biostructure
7.4.1 Creative Biostructure Corporate Summary
7.4.2 Creative Biostructure Business Overview
7.4.3 Creative Biostructure Vaccine Development Service Major Product Offerings
7.4.4 Creative Biostructure Vaccine Development Service Revenue in Global Market (2017-2022)
7.4.5 Creative Biostructure Key News
7.5 PPD
7.5.1 PPD Corporate Summary
7.5.2 PPD Business Overview
7.5.3 PPD Vaccine Development Service Major Product Offerings
7.5.4 PPD Vaccine Development Service Revenue in Global Market (2017-2022)
7.5.5 PPD Key News
7.6 Merck
7.6.1 Merck Corporate Summary
7.6.2 Merck Business Overview
7.6.3 Merck Vaccine Development Service Major Product Offerings
7.6.4 Merck Vaccine Development Service Revenue in Global Market (2017-2022)
7.6.5 Merck Key News
7.7 Sartorius
7.7.1 Sartorius Corporate Summary
7.7.2 Sartorius Business Overview
7.7.3 Sartorius Vaccine Development Service Major Product Offerings
7.7.4 Sartorius Vaccine Development Service Revenue in Global Market (2017-2022)
7.7.5 Sartorius Key News
7.8 Eurofins Scientific
7.8.1 Eurofins Scientific Corporate Summary
7.8.2 Eurofins Scientific Business Overview
7.8.3 Eurofins Scientific Vaccine Development Service Major Product Offerings
7.8.4 Eurofins Scientific Vaccine Development Service Revenue in Global Market (2017-2022)
7.8.5 Eurofins Scientific Key News
7.9 Statens Serum Institut
7.9.1 Statens Serum Institut Corporate Summary
7.9.2 Statens Serum Institut Business Overview
7.9.3 Statens Serum Institut Vaccine Development Service Major Product Offerings
7.9.4 Statens Serum Institut Vaccine Development Service Revenue in Global Market (2017-2022)
7.9.5 Statens Serum Institut Key News
7.10 Thermo Fisher Scientific
7.10.1 Thermo Fisher Scientific Corporate Summary
7.10.2 Thermo Fisher Scientific Business Overview
7.10.3 Thermo Fisher Scientific Vaccine Development Service Major Product Offerings
7.10.4 Thermo Fisher Scientific Vaccine Development Service Revenue in Global Market (2017-2022)
7.10.5 Thermo Fisher Scientific Key News
7.11 TRANSVAC
7.11.1 TRANSVAC Corporate Summary
7.11.2 TRANSVAC Business Overview
7.11.3 TRANSVAC Vaccine Development Service Major Product Offerings
7.11.4 TRANSVAC Vaccine Development Service Revenue in Global Market (2017-2022)
7.11.5 TRANSVAC Key News
7.12 Azenta US
7.12.1 Azenta US Corporate Summary
7.12.2 Azenta US Business Overview
7.12.3 Azenta US Vaccine Development Service Major Product Offerings
7.12.4 Azenta US Vaccine Development Service Revenue in Global Market (2017-2022)
7.12.5 Azenta US Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Vaccine Development Service Market Opportunities & Trends in Global Market
Table 2. Vaccine Development Service Market Drivers in Global Market
Table 3. Vaccine Development Service Market Restraints in Global Market
Table 4. Key Players of Vaccine Development Service in Global Market
Table 5. Top Vaccine Development Service Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Vaccine Development Service Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Vaccine Development Service Revenue Share by Companies, 2017-2022
Table 8. Global Companies Vaccine Development Service Product Type
Table 9. List of Global Tier 1 Vaccine Development Service Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vaccine Development Service Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Vaccine Development Service Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Vaccine Development Service Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Vaccine Development Service Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Vaccine Development Service Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Vaccine Development Service Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Vaccine Development Service Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Vaccine Development Service Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Vaccine Development Service Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Vaccine Development Service Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Vaccine Development Service Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Vaccine Development Service Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Vaccine Development Service Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Vaccine Development Service Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Vaccine Development Service Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Vaccine Development Service Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Vaccine Development Service Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Vaccine Development Service Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Vaccine Development Service Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Vaccine Development Service Revenue, (US$, Mn), 2023-2028
Table 30. WuXi AppTec Corporate Summary
Table 31. WuXi AppTec Vaccine Development Service Product Offerings
Table 32. WuXi AppTec Vaccine Development Service Revenue (US$, Mn), (2017-2022)
Table 33. Charles River Laboratories Corporate Summary
Table 34. Charles River Laboratories Vaccine Development Service Product Offerings
Table 35. Charles River Laboratories Vaccine Development Service Revenue (US$, Mn), (2017-2022)
Table 36. Creative Biolabs Corporate Summary
Table 37. Creative Biolabs Vaccine Development Service Product Offerings
Table 38. Creative Biolabs Vaccine Development Service Revenue (US$, Mn), (2017-2022)
Table 39. Creative Biostructure Corporate Summary
Table 40. Creative Biostructure Vaccine Development Service Product Offerings
Table 41. Creative Biostructure Vaccine Development Service Revenue (US$, Mn), (2017-2022)
Table 42. PPD Corporate Summary
Table 43. PPD Vaccine Development Service Product Offerings
Table 44. PPD Vaccine Development Service Revenue (US$, Mn), (2017-2022)
Table 45. Merck Corporate Summary
Table 46. Merck Vaccine Development Service Product Offerings
Table 47. Merck Vaccine Development Service Revenue (US$, Mn), (2017-2022)
Table 48. Sartorius Corporate Summary
Table 49. Sartorius Vaccine Development Service Product Offerings
Table 50. Sartorius Vaccine Development Service Revenue (US$, Mn), (2017-2022)
Table 51. Eurofins Scientific Corporate Summary
Table 52. Eurofins Scientific Vaccine Development Service Product Offerings
Table 53. Eurofins Scientific Vaccine Development Service Revenue (US$, Mn), (2017-2022)
Table 54. Statens Serum Institut Corporate Summary
Table 55. Statens Serum Institut Vaccine Development Service Product Offerings
Table 56. Statens Serum Institut Vaccine Development Service Revenue (US$, Mn), (2017-2022)
Table 57. Thermo Fisher Scientific Corporate Summary
Table 58. Thermo Fisher Scientific Vaccine Development Service Product Offerings
Table 59. Thermo Fisher Scientific Vaccine Development Service Revenue (US$, Mn), (2017-2022)
Table 60. TRANSVAC Corporate Summary
Table 61. TRANSVAC Vaccine Development Service Product Offerings
Table 62. TRANSVAC Vaccine Development Service Revenue (US$, Mn), (2017-2022)
Table 63. Azenta US Corporate Summary
Table 64. Azenta US Vaccine Development Service Product Offerings
Table 65. Azenta US Vaccine Development Service Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Vaccine Development Service Segment by Type in 2021
Figure 2. Vaccine Development Service Segment by Application in 2021
Figure 3. Global Vaccine Development Service Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Vaccine Development Service Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Vaccine Development Service Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Vaccine Development Service Revenue in 2021
Figure 8. By Type - Global Vaccine Development Service Revenue Market Share, 2017-2028
Figure 9. By Application - Global Vaccine Development Service Revenue Market Share, 2017-2028
Figure 10. By Region - Global Vaccine Development Service Revenue Market Share, 2017-2028
Figure 11. By Country - North America Vaccine Development Service Revenue Market Share, 2017-2028
Figure 12. US Vaccine Development Service Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Vaccine Development Service Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Vaccine Development Service Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Vaccine Development Service Revenue Market Share, 2017-2028
Figure 16. Germany Vaccine Development Service Revenue, (US$, Mn), 2017-2028
Figure 17. France Vaccine Development Service Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Vaccine Development Service Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Vaccine Development Service Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Vaccine Development Service Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Vaccine Development Service Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Vaccine Development Service Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Vaccine Development Service Revenue Market Share, 2017-2028
Figure 24. China Vaccine Development Service Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Vaccine Development Service Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Vaccine Development Service Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Vaccine Development Service Revenue, (US$, Mn), 2017-2028
Figure 28. India Vaccine Development Service Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Vaccine Development Service Revenue Market Share, 2017-2028
Figure 30. Brazil Vaccine Development Service Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Vaccine Development Service Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Vaccine Development Service Revenue Market Share, 2017-2028
Figure 33. Turkey Vaccine Development Service Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Vaccine Development Service Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Vaccine Development Service Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Vaccine Development Service Revenue, (US$, Mn), 2017-2028
Figure 37. WuXi AppTec Vaccine Development Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Charles River Laboratories Vaccine Development Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Creative Biolabs Vaccine Development Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Creative Biostructure Vaccine Development Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. PPD Vaccine Development Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck Vaccine Development Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sartorius Vaccine Development Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Eurofins Scientific Vaccine Development Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Statens Serum Institut Vaccine Development Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Thermo Fisher Scientific Vaccine Development Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. TRANSVAC Vaccine Development Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Azenta US Vaccine Development Service Revenue Year Over Year Growth (US$, Mn) & (2017-2022)